retatrutide women results Timeline: When to Expect Retatrutide UK 2026: Phase 3
Description
Nonetheless, GLP-1RA is known to affect the intestinal environment and, indeed, changes in the gut microbiota have been linked to GLP-1RAs 26,27,28
Do I need to stay on GLP-1 medication forever
As of mid-2025, no UK marketing authorisation has been granted for retatrutide
#LucidQuest #PharmaCI To view or add a comment, sign in New weight loss drug FDA approves first oral GLP-1 drug for obesity: The FDA has approved Novo Nordisk's oral semaglutide for obesity, making it the first GLP-1 pill for weight loss
